differences between alzheimer’s disease biomarkers: p-tau181, p-tau231 & p-tau217
Published 2 years ago • 762 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:13
plasma p-tau181 and p-tau231 offer complementary information in alzheimer's
-
2:20
the ability of plasma p-tau231 to detect preclinical alzheimer’s disease
-
3:09
head-to-head comparison of p-tau species for alzheimer’s disease detection in a real-world cohort
-
2:47
latest knowledge on plasma p-tau in alzheimer’s disease
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
1:32
investigating novel plasma-based p-tau biomarkers
-
5:19
examining plasma vs. csf p-tau217 in preclinical and prodromal alzheimer’s disease
-
2:25
comparing the performance of novel biomarkers across the spectrum of alzheimer’s disease
-
1:58
the value of plasma p-tau181 as a screening and diagnostic tool for alzheimer’s disease
-
2:46
value of p-tau231 in early alzheimer’s disease
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
2:55
research priorities to achieve widespread use of blood-based biomarkers in alzheimer’s disease
-
2:17
potential markers for alzheimer’s disease: plasma p-tau181/aβ1-42
-
1:12
beyond aβ and p-tau: novel biomarkers under investigation for alzheimer’s disease
-
3:17
blood biomarkers for the differential diagnosis of alzheimer’s disease in clinical practice
-
0:51
decoding #alzheimer's disease : the truth behind blood #biomarkers
-
2:09
alzheimer’s disease plasma biomarkers across the spectrum: which perform best?
-
2:48
biomarkers for alzheimer’s disease in a preclinical setting
-
8:58
new blood test for early detection for alzheimer's disease | plasma biomarker p-tau217